Postdoc: Spatial Proteomics & Quantitative MS for Cancer

Department of Pharmacy, University of Copenhagen; United States; On-site; USD 306,000 - 366,000; Part time

Job summary

University of Copenhagen is seeking a highly motivated postdoc to develop mass spectrometry-based spatial proteomics workflows for FFPE cancer samples. You will join the Olsen Group within the Center for Glycocalyx Research, contributing to translational cancer research using the Orbitrap Astral Zoom platform.

The role is a part-time 2-year position starting Jan 1, 2027, with emphasis on scalable sample prep, LMD enrichment, and DIA methods in a multidisciplinary team.

Qualifications

• PhD in Life Sciences or related field.
• First- or co-author publications in spatial proteomics or phosphoproteomics.
• Experience analyzing large proteomics cohorts and performing quality checks.
• Strong mass spectrometry proteomics background with FFPE samples.
• Bioinformatics analysis of large proteomic datasets.
• Bioinformatics for spatial-proteomics data.
• Experience with DIA workflows and optimization.
• Excellent English written and spoken.

Responsibilities

• Develop scalable workflows for plasma and EV proteomics in large cohorts.
• Lead spatial phosphoproteomics workflows for FFPE biopsy material.
• Integrate LMD, whole-slide imaging, and ultra-sensitive nDIA-MS on Orbitrap Astral Zoom.
• Contribute to translational cancer research through quantitative spatial data.

Skills

Mass spectrometry-based proteomics

Spatial proteomics

Phosphoproteomics

Large cohort analysis

Bioinformatics analysis

DIA workflows

Team collaboration

Excellent English

Education

PhD in Life Sciences or related

Tools

Orbitrap Astral Zoom MS

Vanquish NEO LC

Evosep ENO LC

Job description

University of Copenhagen is seeking a highly motivated postdoc to develop mass spectrometry-based spatial proteomics workflows for FFPE cancer samples. You will join the Olsen Group within the Center for Glycocalyx Research, contributing to translational cancer research using the Orbitrap Astral Zoom platform.

The role is a part-time 2-year position starting Jan 1, 2027, with emphasis on scalable sample prep, LMD enrichment, and DIA methods in a multidisciplinary team.